Paul Morgan

Morgan's Paintbox

Paul Morgan, 2007 .

Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.

Wei Li, Xin Xu, Paul Morgan, 2009, Journal of medicinal chemistry.

A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).

Wei Li, Xin Xu, Paul Morgan, 2009, Journal of medicinal chemistry.

Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival.

Paul Morgan, J. Arrowsmith, P. H. van der Graaf, 2012, Drug discovery today.

Directional trans-epithelial transport of organic anions in porcine LLC-PK1 cells that co-express human OATP1B1 (OATP-C) and MRP2.

C Roland Wolf, Paul Morgan, Clive J Ward, 2005, Biochemical pharmacology.

The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance

Hugh A Barton, Hannah M Jones, Maurice Dickins, 2012, Xenobiotica; the fate of foreign compounds in biological systems.